AB Science completes EUR 14.2 million private placement
Reuters2026/08/10 05:55- AB Science priced a EUR 14.2 million private placement via unregistered share sales to a small group of investors.
- Existing long-term investor subscribed EUR 12 million; CEO Stéphane Ledermann also invested.
- Issued 23,278,692 new shares at EUR 0.61 each, a 24.87% discount to the prior 3-day VWAP of EUR 0.81.
- Each share carries a warrant; full exercise would add 36,590,166 shares, raising about EUR 36 million at EUR 1 per share.
- Cash position seen around EUR 23 million; proceeds earmarked for R&D, including AB8939 in AML, masitinib in ALS.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Securitize to Help Develop Dubai’s Regulated Tokenized Asset Market
Audley Travel to open concessions in nine John Lewis stores from November 2026
Tessin Nordic Holding announces extraordinary shareholder meeting
Will a 10-year US Treasury yield rising to 5.5% "attack" US stocks? Societe Generale warns: this could be the valuation tipping point.
Bokobza, Global Head of Asset Allocation at Société Générale, pointed out that if the 10-year U.S. Treasury yield reaches 5.5%, corporate profit growth will not be sufficient to offset the impact of rising rates on valuations, and the stock market will face substantial pressure. However, he believes that the upcoming rate hikes by the Federal Reserve and the European Central Bank will be relatively limited and will not disrupt the current economic cycle.
Crypto prices
More
